MicroRNA-384 Inhibits the Progression of Papillary Thyroid Cancer by Targeting PRKACB

Figure 1

miR-384 was decreased and correlated with the clinicopathological characteristics of PTC. (a) Expression of miR-384 in 58 cases of fresh human PTC tissues and their paired adjacent noncancerous tissues by real-time PCR analysis; miR-384 expression was normalized to U6 and expressed relative to the matched adjacent normal tissues (2^−ΔΔCт). (b) Mean expression of miR-384 in 58 cases of fresh human PTC tissues and their paired adjacent noncancerous tissues by real-time PCR (ΔCт, mean ± SD, n = 58, ). (c) Expression of miR-384 by real-time PCR according to the primary tumor size (ΔCт, mean ± SD, n = 58, ). (d) Expression of miR-384 by real-time PCR according to the lymph node metastasis (ΔCт, mean ± SD, n = 58, ).

(a)

(b)

(c)

(d)